Table of Contents “...Renal disorders -- section 5. Neurologic disorders -- section 6. Psychiatric disorders -- section 7. ...”

Table of Contents “...Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders....”